Recent patents of dipeptidyl peptidase IV inhibitors (Q37948110)

25 August 2017

title

Recent patents of dipeptidyl peptidase IV inhibitors (English)

1 reference

25 August 2017

0 references

Ernest Giralt i Lledó

object named as

Ernest Giralt

series ordinal

3

0 references

author name string

Laura Mendieta

series ordinal

1

1 reference

25 August 2017

Teresa Tarrago

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

Expert Opinion on Therapeutic Patents

25 August 2017

published in

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1693-1741

1 reference

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Transcript imaging of the development of human T helper cells using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Regulation of glucagon secretion by incretins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Trophic effects of PACAP on pancreatic islets: a mini-review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Secretin and body fluid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The gut hormone peptide YY regulates appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The role of substance P in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The islet-acinar axis of the pancreas: more than just insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The dipeptidyl peptidase IV family in cancer and cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Ongoing and future developments at the Universal Protein Resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

DPP-4 inhibitors: what may be the clinical differentiators?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Novel aspects of cellular action of dipeptidyl peptidase IV/CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.627325

Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.422

Identifiers

DOI

10.1517/13543776.2011.627325

1 reference

25 August 2017

1 reference